Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

Published:2015-03-13 Issue:6 Volume:70 Page:707-710
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Senti G.¹,Moos S.²,Tay F.¹,Graf N.³,Johansen P.⁴,Kündig T. M.⁴

Affiliation:

1. Clinical Trials Center University of Zurich Zurich Switzerland

2. Department of Internal Medicine University Hospital Zurich Zurich Switzerland

3. Graf Biostatistics Winterthur Switzerland

4. Department of Dermatology University Hospital Zurich Zurich Switzerland

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.12600

Reference15 articles.

1. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT)

2. Sublingual immunotherapy: A comprehensive review

3. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy

4. Antigen presentation by Langerhans cells

5. Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective;The Journal of Allergy and Clinical Immunology: In Practice;2024-01

2. Challenging the norm: Epicutaneous immunotherapy for canine atopic dermatitis;Allergy;2023-11-20

3. Promising New Diagnostic and Treatment Modalities for Allergic Rhinitis;Otolaryngologic Clinics of North America;2023-09

4. Innovative delivery systems for epicutaneous immunotherapy;Frontiers in Immunology;2023-08-22

5. Allergen immunotherapy: progress and future outlook;Expert Review of Clinical Immunology;2023-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3